These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


309 related items for PubMed ID: 19331217

  • 1. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
    Nishimura G, Tsukuda M, Mikami Y, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Kawakami M, Watanabe M, Niho T, Abo H, Yamomoto S.
    Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
    Morimoto M, Takemura H, Yui T, Suzuki T, Sanbe T, Suzaki H.
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1903-6. PubMed ID: 20948253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
    Czito BG, Cohen DP, Kelsey CR, Lockhart AC, Bendell JC, Willett CG, Petros WP, D'Amico TA, Truax R, Hurwitz HI.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1066-72. PubMed ID: 17881149
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T, Nishimura G, Takahashi M, Komatsu M, Sano D, Sakuma N, Arai Y, Yamashita Y, Shiono O, Hirama M, Sakuma Y, Ishitoya J, Hata M, Ogino I, Oridate N.
    Cancer Chemother Pharmacol; 2013 Oct 15; 72(4):837-43. PubMed ID: 23959463
    [Abstract] [Full Text] [Related]

  • 13. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS, Chung WK, Ahn SJ, Nam TK, Nah BS, Song JY, Lim SC, Lee JK.
    Acta Otolaryngol; 2008 May 15; 128(5):590-6. PubMed ID: 18421617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
    Nonoshita T, Shioyama Y, Kunitake N, Nakamura K, Nomoto S, Ohga S, Toriya Y, Ono M, Honda H.
    Fukuoka Igaku Zasshi; 2009 Jan 15; 100(1):26-31. PubMed ID: 19378773
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
    McRackan TR, Watkins JM, Herrin AE, Garrett-Mayer EM, Sharma AK, Day TA, Gillespie MB.
    Laryngoscope; 2008 Jul 15; 118(7):1180-5. PubMed ID: 18475213
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.